Hu Jing-Jing, Lin Hai-Shuang, Zhang Shao-Dan, Ye Wen-Qing, Gu Juan, Xie Yan-Qian, Tang Yi-Hua, Liang Yuan-Bo
The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.
Glaucoma Institute, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.
Int J Ophthalmol. 2022 Jul 18;15(7):1077-1081. doi: 10.18240/ijo.2022.07.06. eCollection 2022.
To report the outcomes of penetrating canaloplasty for corticosteroid-induced glaucoma in a case series.
Penetrating canaloplasty is a bleb-independent filtering surgery unifying canaloplasty and trabeculectomy. In this study, the surgery was performed to restore the natural outflow through surgically expanded Schlemm's canal and generated trabeculum ostium. A total of 10 eyes of 8 patients were treated with penetrating canaloplasty for corticosteroid-induced glaucoma. Intraocular pressure (IOP) and the number of glaucoma medications at postoperative 3, 6, 12, 18, 24, 36, and 48mo were documented as primary endpoint. Complications after the surgery were recorded as secondary endpoint.
Penetrating canaloplasty was accomplished successfully for all 10 eyes, with a mean follow-up of 20.4±13.0mo (range 6-48mo). The mean preoperative IOP and number of anti-glaucoma medications were 45.1±6.5 mm Hg and 3.3±0.5 respectively. The mean post-operative IOP at 3, 6, 12, 18, 24, 36, and 48mo were 15.8±6.0, 14.7±3.3, 15.3±2.0, 15.6±2.6, 17.5±1.8, 16.5±4.9, and 14.0 mm Hg. The number of anti-glaucoma medications at these time points were all 0. This surgery failed to control the IOP in 1 eye at 1mo after surgery. Hyphaema occurred in 3 eyes on the first day after surgery. Postoperative transient IOP increasing was encountered with in two eyes from 1wk to 1mo after surgery. Choroidal detachment developed in one eye but responded well to conservative treatment.
Penetrating canaloplasty is effective for corticosteroid-induced glaucoma without serious complications, making it a viable or preferred alternative option.
报告穿透性房角成形术治疗激素性青光眼系列病例的结果。
穿透性房角成形术是一种不依赖于滤过泡的滤过性手术,它结合了房角成形术和小梁切除术。在本研究中,该手术通过手术扩张施莱姆管并形成小梁开口来恢复自然房水流出。共有8例患者的10只眼睛接受了穿透性房角成形术治疗激素性青光眼。记录术后3、6、12、18、24、36和48个月时的眼压(IOP)和青光眼药物使用数量作为主要终点指标。记录手术并发症作为次要终点指标。
10只眼睛的穿透性房角成形术均成功完成,平均随访时间为20.4±13.0个月(范围6 - 48个月)。术前平均眼压和抗青光眼药物使用数量分别为45.1±6.5 mmHg和3.3±0.5。术后3、6、12、18、24、36和48个月时的平均眼压分别为15.8±6.0、14.7±3.3、15.3±2.0、15.6±2.6、17.5±1.8、16.5±4.9和14.0 mmHg。这些时间点的抗青光眼药物使用数量均为0。术后1个月时1只眼睛手术未能控制眼压。术后第1天有3只眼睛发生前房积血。术后1周内至1个月有2只眼睛出现短暂性眼压升高。1只眼睛发生脉络膜脱离,但保守治疗效果良好。
穿透性房角成形术治疗激素性青光眼有效且无严重并发症,是一种可行或优选的替代选择。